On 2026-03-19, Mereo BioPharma Group plc - Sponsored ADR (MREO) announced earnings per share of $-0.01 for the fiscal quarter ending 2025-12-31, meeting the average analyst estimate of $-0.01.
The next expected annoucement date for quarterly earnings is 2026-05-12, with an average estimated earnings per share of $0.01 for the fiscal quarter ending 2026-03-31.
Note: Earnings figures are calculated as diluted earnings per share before non-recurring items and including employee stock options expenses.
| Announcement Date | Fiscal Quarter End | Estimated EPS | Actual EPS |
|---|---|---|---|
| 2026-03-19 | 2025-12-31 | $-0.01 | $-0.01 |
| 2025-11-10 | 2025-09-30 | $0.00 | $-0.01 |
| 2025-08-12 | 2025-06-30 | $-0.01 | $-0.02 |
| 2025-05-13 | 2025-03-31 | $-0.01 | $-0.02 |
| 2025-03-26 | 2024-12-31 | $-0.02 | $-0.01 |
| 2024-11-12 | 2024-09-30 | -- | $-0.02 |
| 2024-08-13 | 2024-06-30 | -- | $-0.02 |
| 2024-05-15 | 2024-03-31 | -- | $-0.01 |